Retinoic acid receptor and Retinoid X receptor (RAR and RXR)

Retinoic acid receptor (RAR) and Retinoid X receptor (RXR) are two distinct but functionally interrelated nuclear hormone receptors. Both act as ligand-activated transcription factors that regulate gene expression in response to retinoic acids (RARs) or rexinoids (RXRs)[5][6][4]. RAR and RXR each have three isotypes (α, β, γ), and can form heterodimers (most commonly as RAR–RXR) to bind specific DNA response elements, regulating genes critical for development, cell differentiation, immune function, metabolism, and apoptosis[4][5][6][2]. RXR is a central “hub” for many nuclear receptor pathways due to its ability to heterodimerize with numerous partners (e.g., PPAR, LXR, VDR, FXR, TR, and more), shaping diverse biological outcomes and making it a critical therapeutic target in cancer, metabolic, and immune diseases[1][3][2][6]. Both receptor families are targets for several clinically important drugs (notably, all-trans-retinoic acid in leukemia and bexarotene in cutaneous T-cell lymphoma), but their use is limited by toxicity risks, teratogenicity, endocrine disturbances, and other on-target side effects[1][7]. RAR/RXR signaling is an area of active research for novel therapies and roles as disease biomarkers. Note: For structured bioinformatics resources, RAR and RXR should ideally be separated into their individual canonical entries, each with its unique gene (e.g., RARA, RXRA), ligand specificity, and drug associations, though their heterodimerization is biologically and therapeutically highly relevant[5][4][6].

Other names

RAR (for Retinoic acid receptor)RXR (for Retinoid X receptor)Retinoic acid receptor alpha/beta/gamma (RARα, RARβ, RARγ)Retinoid X receptor alpha/beta/gamma (RXRα, RXRβ, RXRγ)Nuclear receptor subfamily 1, group C member 1/2/3 (for RARs: NR1C1–3)Nuclear receptor subfamily 2, group B member 1/2/3 (for RXRs: NR2B1–3)

Ligand binding (retinoic acids, rexinoids) causes conformational changes enabling recruitment of coactivators and facilitating transcription of target genes. Receptor acts as a ligand-regulated transcription factor, controlling gene expression. RXR forms heterodimers with multiple nuclear receptors, serving as a central co-regulator.